PURE - PURE Bioscience, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue1,289729550
Cost of Revenue441285344
Gross Profit848444206
Operating Expenses
Research Development9277901,032
Selling General and Administrative6,9787,2948,322
Non Recurring--2,754
Total Operating Expenses---
Operating Income or Loss-7,057-7,640-11,902
Income from Continuing Operations
Total Other Income/Expenses Net-7,30421862
Earnings Before Interest and Taxes-14,361-7,619-11,767
Interest Expense10810
Income Before Tax-14,371-7,627-11,777
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-14,371-7,627-11,050
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-14,371-7,627-11,050
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-14,371-7,627-11,050